Oncology reports · 2017
Overexpression of ARF1 is associated with cell proliferation and migration through PI3K signal pathway in ovarian cancer.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gu Guifang, Chen Yannan, Duan Chengwei, Zhou Linsen, Chen Caiwen, Chen Jie, Cheng Jialin, Shi Nannan, Jin Yunfeng, Xi Qinghua, Zhong Jianxin
Аннотация
ADP-ribosylation factor 1 (ARF1) is a small G protein that regulates many cellular processes such as reorganization of the actin cytoskeleton and is highly expressed in various tumor cells and tissues. However, the role of ARF1 in ovarian cancer progression remains unknown. In the present study, we explored the expression patterns of ARF1 in clinical ovarian cancer samples and adjacent noncancerous tissues. The results revealed that ARF1 overexpressed in EOC tissues and cell lines, compared with the adjacent non-tumorous tissues and normal ovarian cells. In addition, the immunoreactivity of ARF1 was positively correlated with EOC grade and Ki-67 expression. Knockdown of ARF1 expression notably inhibited cell proliferation and migration rate of EOC cells by the auxiliary of PI3K. Taken together, our findings provide new insights into the functional role of ARF1 on EOC cell growth and migration and it may serve as a diagnostic and therapeutic target.
Предметные рубрики MeSH
ADP-Ribosylation Factor 1Adenocarcinoma, Clear CellAdenocarcinoma, MucinousAdultAgedAged, 80 and overApoptosisBiomarkers, TumorBlotting, WesternCell CycleCell ProliferationCystadenocarcinoma, SerousEndometrial NeoplasmsFemaleFluorescent Antibody TechniqueGene Expression Regulation, NeoplasticHumansImmunoenzyme TechniquesImmunoprecipitationMiddle AgedNeoplasm GradingNeoplasm StagingOvarian NeoplasmsPhosphatidylinositol 3-KinasesPrognosisTumor Cells, CulturedWound HealingYoung Adult